LAB Share Price Performance
€3.70
0.70 (23.33%)
Price €3.70
Share Price€3.70
LAB Community Narratives
There are no narratives available yet.
Recent LAB News & Updates
No updates
Labiana Health, S.A. Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0.036
- Gross Margin
- 57.75%
- Net Profit Margin
- 0.38%
- Debt/Equity Ratio
- 1,343.1%
Labiana Health, S.A. Competitors
About LAB
- Founded
- 1958
- Employees
- 369
- CEO
- WebsiteView website
Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized, and biological formats; and Fosfomycin trometamol under the Fosfomicina Labiana brand name. In addition, the company offers contract developments and manufacturing services. Labiana Health S.A. was founded in 1958 and is based in Pozuelo de Alarcón, Spain.
Spanish Market Performance
- 7 Days: -1.2%
- 3 Months: 3.0%
- 1 Year: 25.3%
- Year to Date: 16.7%
Over the last 7 days, the market has dropped 1.2%, driven by a decline of 4.9% in the Consumer Discretionary sector. In the last year, the market is actually up 25%. As for the next few years, earnings are expected to grow by 4.5% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading